AMEX
2.73USD
+0.04 (+1.49%)
We have scored 4 news catalysts on Serina Therapeutics, Inc. (SER) over the past 12 months. The biggest single-day move next to one of them came Mar 18, 2026, when SER closed −4.5%: “Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson's Disease”. Coverage across the window leans positive (average ticker sentiment +0.71). Most of the impact sits in price momentum and sector healthcare.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Latest scored catalyst for SER: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Market cap
40.9M
P/E
—
EPS
—
Beta
0.03
52W range
1.22-5.83
Day range
2.51–2.74
Open
2.61
Prev close
2.69
Volume
14.8K
Avg volume
76.8K
Dividend
0.00
IPO
2018-11-28
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Serina Therapeutics, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
